Masashi Kudo

566 total citations
38 papers, 401 citations indexed

About

Masashi Kudo is a scholar working on Oncology, Surgery and Hepatology. According to data from OpenAlex, Masashi Kudo has authored 38 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 13 papers in Surgery and 13 papers in Hepatology. Recurrent topics in Masashi Kudo's work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Liver Disease Diagnosis and Treatment (7 papers). Masashi Kudo is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Liver Disease Diagnosis and Treatment (7 papers). Masashi Kudo collaborates with scholars based in Japan, United States and United Kingdom. Masashi Kudo's co-authors include Naoto Gotohda, Shinichiro Takahashi, Masaru Konishi, Motokazu Sugimoto, Yusuke Nakayama, Yasunori Nishida, Yuichiro Kato, Shin Kobayashi, Atsushi Hiraoka and Kojiro Michitaka and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Masashi Kudo

34 papers receiving 394 citations

Peers

Masashi Kudo
Alyson A. Melin United States
C.D. Mann United Kingdom
Nicholas G. Berger United States
Alyson A. Melin United States
Masashi Kudo
Citations per year, relative to Masashi Kudo Masashi Kudo (= 1×) peers Alyson A. Melin

Countries citing papers authored by Masashi Kudo

Since Specialization
Citations

This map shows the geographic impact of Masashi Kudo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masashi Kudo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masashi Kudo more than expected).

Fields of papers citing papers by Masashi Kudo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masashi Kudo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masashi Kudo. The network helps show where Masashi Kudo may publish in the future.

Co-authorship network of co-authors of Masashi Kudo

This figure shows the co-authorship network connecting the top 25 collaborators of Masashi Kudo. A scholar is included among the top collaborators of Masashi Kudo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masashi Kudo. Masashi Kudo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kobayashi, Shin, Daichi Kitaguchi, Masashi Kudo, et al.. (2024). Intraoperative artificial intelligence system identifying liver vessels in laparoscopic liver resection: a retrospective experimental study. Surgical Endoscopy. 38(2). 1088–1095. 9 indexed citations
3.
Kobayashi, Shin, Motohiro Kojima, Masashi Kudo, et al.. (2024). Survival outcome of patient with pT1N0 biliary tract cancer treated with surgery alone. European Journal of Surgical Oncology. 50(3). 107980–107980. 1 indexed citations
5.
6.
Kojima, Motohiro, Toshiyuki Suzuki, Genichiro Ishii, et al.. (2023). Relationships between physical and immunological tumor microenvironment in pancreatic ductal adenocarcinoma. Cancer Science. 114(9). 3783–3792. 3 indexed citations
7.
8.
Qin, Shukui, Masashi Kudo, T Meyer, et al.. (2022). LBA36 Final analysis of RATIONALE-301: Randomized, phase III study of tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma. Annals of Oncology. 33. S1402–S1403. 54 indexed citations
9.
Ito, Masaaki, Shin Kobayashi, Daichi Kitaguchi, et al.. (2022). Automated surgical workflow identification by artificial intelligence in laparoscopic hepatectomy: Experimental research. International Journal of Surgery. 105. 106856–106856. 13 indexed citations
10.
Sugimoto, Motokazu, Masashi Kudo, Shin Kobayashi, et al.. (2022). Early postoperative decrease of skeletal muscle mass predicts recurrence and poor survival after surgical resection for perihilar cholangiocarcinoma. BMC Cancer. 22(1). 1358–1358. 8 indexed citations
11.
Hashimoto, Taiki, Yasushi Yatabe, Motohiro Kojima, et al.. (2021). APC mutations are common in adenomas but infrequent in adenocarcinomas of the non-ampullary duodenum. Journal of Gastroenterology. 56(11). 988–998. 8 indexed citations
12.
Kudo, Masashi, Shin Kobayashi, Motohiro Kojima, et al.. (2021). Impact of previous history of choledochojejunostomy on the incidence of organ/space surgical site infection after hepatectomy. Asian Journal of Surgery. 44(12). 1520–1528. 1 indexed citations
13.
Merle, P., Masashi Kudo, Catherine Frenette, et al.. (2020). 1010P Real-world dosing of regorafenib (REG) in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Interim analysis (IA) of the observational REFINE study. Annals of Oncology. 31. S699–S700. 3 indexed citations
14.
Kudo, Masashi, Tatsushi Kobayashi, Naoto Gotohda, et al.. (2020). Clinical Utility of Histological and Radiological Evaluations of Tumor Necrosis for Predicting Prognosis in Pancreatic Cancer. Pancreas. 49(5). 634–641. 12 indexed citations
15.
Kudo, Masashi, Naoto Gotohda, Motokazu Sugimoto, et al.. (2018). Evaluation of liver function using gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging based on a three-dimensional volumetric analysis system. Hepatology International. 12(4). 368–376. 18 indexed citations
16.
Hiraoka, Atsushi, Kojiro Michitaka, Takashi Kumada, & Masashi Kudo. (2017). ALBI Score as a Novel Tool in Staging and Treatment Planning for Hepatocellular Carcinoma: Advantage of ALBI Grade for Universal Assessment of Hepatic Function. Liver Cancer. 6(4). 377–379. 33 indexed citations
17.
Nishida, Yasunori, Yuichiro Kato, Masashi Kudo, et al.. (2016). Preoperative Sarcopenia Strongly Influences the Risk of Postoperative Pancreatic Fistula Formation After Pancreaticoduodenectomy. Journal of Gastrointestinal Surgery. 20(9). 1586–1594. 98 indexed citations
18.
Nakayama, Yusuke, Masaru Konishi, Naoto Gotohda, et al.. (2016). Comparison of postoperative early and late complications between pancreas-sparing duodenectomy and pancreatoduodenectomy. Surgery Today. 47(6). 705–711. 13 indexed citations
19.
Kudo, Masashi. (2003). 2.Local ablation therapy. Kanzo. 44(6). 250–258. 1 indexed citations
20.
Takeo, Teruko, Masashi Kudo, & Yasuo Sakuma. (1995). Stria terminalis conveys a facilitatory estrogen effect on female rat lordosis reflex. Neuroscience Letters. 184(2). 79–81. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026